At a glance
| Molecular size | Nine amino acids |
|---|---|
| Studied form | Nonapeptide-1 acetate |
| Proposed pathway | Alpha-MSH / MC1R signaling |
| Direct source type | Cultured human skin-cell experiments |
| Clinical gap | Controlled isolated-ingredient human outcomes |
Overview
Nonapeptide-1 is a nine-residue peptide used in research on the signaling that controls melanin production. The acetate form appears in published cell experiments. Its presence as a cosmetic ingredient should be distinguished from a prescription treatment for a pigment disorder. Skin pigmentation is influenced by several cell types, ultraviolet exposure, inflammation, and hormonal factors; a favorable result in one signaling pathway does not resolve all of those contributors. Its pigmentation-related research rationale is scientifically relevant, while the evidence supporting visible benefit in people remains much less developed. Laboratory activity is relevant, but direct controlled human outcomes remain the missing link for broad efficacy claims.
How it works
The research rationale involves antagonism of alpha-melanocyte-stimulating-hormone signaling at the melanocortin-1 receptor. In a study primarily investigating tea polyphenols, nonapeptide-1 acetate was used as a pathway-related comparator and influenced melanogenesis-associated measurements. This supports a laboratory role in the pathway, but does not demonstrate the exposure, magnitude, persistence, or safety of an effect after ordinary topical application.
What the cited experiment actually studied
The 2022 paper focused on tea polyphenols and used human keratinocytes and melanocytes exposed to UVA. Nonapeptide-1 acetate was included in comparator and combination conditions. The investigators measured melanin, tyrosinase-related activity, and signaling proteins. These are cell-culture endpoints; the paper did not enroll people with dark spots or test a finished cosmetic cream.
Supporting sources [1]
Do not transfer the paper’s headline conclusion
Results attributed to tea polyphenols or a combination cannot all be attributed to nonapeptide-1. Likewise, lower melanin in a controlled cell system does not show how a peptide crosses intact skin or whether visible benefit lasts. A clinical study would need an appropriate vehicle control, standardized photography or color measurement, and follow-up.
Supporting sources [1]
Pigmentation claims need a defined scope
Cosmetic status is not FDA drug approval. The available experiment does not establish long-term tolerability, use on all skin types, or treatment of a medical pigment disorder. Appearance-related product claims should remain specific to tested formulations, without treating the ingredient name or pathway rationale as an approval.
Supporting sources [2]
Reading this profile
Jurisdiction: United States; status and indications may differ elsewhere. Molecular class: Synthetic melanocortin-pathway nonapeptide.
This profile was written with AI-assisted research and checked against the linked sources. It has not been represented as a clinician’s review. Evidence summaries describe the cited studies and products; they do not establish that a separately purchased preparation is equivalent.
Sources & references
Follow the original material. Product labels define specific formulations and uses; trial registration describes a study and does not by itself establish benefit.
- Tea polyphenols and UVA-induced melanogenesis, including nonapeptide-1 comparator experiments ↗Original research · Checked 2026-10-27
- FDA: authority over cosmetics and the distinction from drug approval ↗Regulatory source · Checked 2026-10-27